Ideas

February 2, 2019

Published by admin_auro at February 2, 2019

Categories

Molecular therapy for alleviating Diabetes: Alogliptin, an antidiabetic drug in the DPP-4 inhibitor class, increases GLP1R and Caveolin-1 (CAV-1) expression, promotes glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 2/February/2019, 5.54 pm

Introduction: What they say A study from the Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, […]

February 2, 2019

Published by admin_auro at February 2, 2019

Categories

Molecular therapy for safeguarding your heart against cardiac dysfunction: Sofalcone, a gastrointestinal medication, decreases tumor suppressor Mir-128 and cyclin-dependent kinase inhibitor p27 expression, increases SUZ12 expression, increases Cyclin E and CDK2 expression, promotes proliferation/re-entry of postnatal/adult cardiomyocytes, attenuates fibrosis, ameliorates cardiac dysfunction, and promotes heart repair in response to myocardial infarction, via up-regulation of its target gene, 2/February/2019, 5.44 pm

Introduction: What they say: A recent study from Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA; Key Laboratory […]

February 2, 2019

Published by admin_auro at February 2, 2019

Categories

Alleviating Diabetes with amino acid Alanine: L-Alanine, a non-essential amino acid, increases GLP1R and Caveolin-1 (CAV-1) expression, promotes glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 2/February/2019, 1.27 pm

Introduction: What they say A study from the Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, […]

January 31, 2019

Published by admin_auro at January 31, 2019

Categories

Molecular therapy for Diabetes Mellitus: CLOCK and BMAL1 augment the expression of FGF19 and FGF1, attenuate hepatic glucose production, decrease hepatic acetyl CoA content, bring down the levels of plasma ACTH, and corticosterone, augment insulin sensitivity, promote weight loss and alleviate TIDM, via upregulation of its target gene, 31/January/2018, 11.51pm

Introduction: What they say A study from Diabetes and Obesity Center of Excellence, Department of Medicine, University of Washington, Seattle, Washington, USA shows that Central injection […]